COR - Cencora - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US03073E1055
Pharmaceuticals, Vaccines, Diagnostics, Healthcare Products, Blood Products
Cencora, Inc. is a leading pharmaceutical sourcing and distribution company that operates through two primary segments: U.S. Healthcare Solutions and International Healthcare Solutions.
The U.S. Healthcare Solutions segment is a comprehensive provider of pharmaceutical products, services, and solutions to a diverse range of customers, including acute care hospitals, health systems, retail pharmacies, mail order pharmacies, medical clinics, and long-term care facilities. The company distributes a broad portfolio of pharmaceuticals, over-the-counter healthcare products, home healthcare supplies, and equipment, as well as provides value-added services such as pharmacy management, staffing, and consulting services. Additionally, Cencora offers supply management software, packaging solutions, clinical trial support, product post-approval, and commercialization support services to its customers.
In the animal health sector, Cencora distributes pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. The company also provides sales force services to manufacturers, helping them to reach a wider customer base.
Furthermore, Cencora's U.S. Healthcare Solutions segment offers specialized services to physicians and healthcare providers, including those who specialize in oncology and other disease states. The company distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products, and provides additional services to hospitals, dialysis clinics, and other healthcare providers.
The International Healthcare Solutions segment focuses on international pharmaceutical wholesale and related services, distributing pharmaceuticals, healthcare products, and services to pharmacies, doctors, health centers, and hospitals primarily in Europe. Cencora also provides global commercialization services and specialty transportation and logistics services for the biopharmaceutical industry.
Headquartered in Conshohocken, Pennsylvania, Cencora, Inc. was formerly known as AmerisourceBergen Corporation and changed its name in August 2023. The company was incorporated in 2001 and has since established itself as a leading player in the pharmaceutical sourcing and distribution industry.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
COR Stock Overview
Market Cap in USD | 38,516m |
Sector | Healthcare |
Industry | Medical Distribution |
GiC SubIndustry | Health Care Distributors |
TER | 0.00% |
IPO / Inception | 1995-04-04 |
COR Stock Ratings
Growth 5y | 92.4 |
Fundamental | 46.3 |
Dividend | 55.5 |
Rel. Performance vs Sector | -0.37 |
Analysts | 4.11/5 |
Fair Price Momentum | 249.15 USD |
Fair Price DCF | 277.17 USD |
COR Dividends
Dividend Yield 12m | 0.89% |
Yield on Cost 5y | 2.48% |
Dividends CAGR 5y | 4.20% |
Payout Consistency | 99.8% |
COR Growth Ratios
Growth 12m | 23.19% |
Growth Correlation 12m | 63% |
Growth Correlation 3m | 2% |
CAGR 5y | 22.80% |
CAGR/Mean DD 5y | 4.39 |
Sharpe Ratio 12m | 1.10 |
Alpha vs SP500 12m | 8.44 |
Beta vs SP500 5y weekly | 0.61 |
ValueRay RSI | 49.44 |
Volatility GJR Garch 1y | 14.88% |
Price / SMA 50 | 0.4% |
Price / SMA 200 | 3.59% |
Current Volume | 1310.3k |
Average Volume 20d | 1161.5k |
External Links for COR Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of July 27, 2024, the stock is trading at USD 227.62 with a total of 1,310,278 shares traded.
Over the past week, the price has changed by +1.52%, over one month by -4.71%, over three months by -5.06% and over the past year by +22.91%.
According to ValueRays Forecast Model, COR Cencora will be worth about 273.1 in July 2025. The stock is currently trading at 227.62. This means that the stock has a potential upside of +19.98%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 212.3 | -6.75 |
Analysts Target Price | 209.7 | -7.88 |
ValueRay Target Price | 273.1 | 20.0 |